https://www.selleckchem.com/products/cc-92480.html
55 (95% confidence interval [CI] = 0.38-0.78) per 100,000 person-months (which corresponds to a risk of CVT within the first 31 days of 0.55 per 100,000 individuals) for all vaccines and 1.52 (95% CI=1.00-2.21) for ChAdOx1 (after 2,320,535 ChAdOx1 first doses). The adjusted incidence rate ratio was 9.68 (95% CI=3.46-34.98) for ChAdOx1 compared to mRNA-based vaccines and 3.14 (95% CI=1.22-10.65) for females compared to non-females. In 26 of 45 patients with CVT (57.8%), VITT was graded highly probable. Given an incidence of 0.02 to 0.15
Like
Comment
Share
